EMIT QST CARBAMAZEPINE ASSAY

K882961 · Syva Co. · KLT · Aug 29, 1988 · Clinical Toxicology

Device Facts

Record IDK882961
Device NameEMIT QST CARBAMAZEPINE ASSAY
ApplicantSyva Co.
Product CodeKLT · Clinical Toxicology
Decision DateAug 29, 1988
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 862.3645
Device ClassClass 2

Regulatory Classification

Identification

A neuroleptic drugs radioceptor assay test system is a device intended to measure in serum or plasma the dopamine receptor blocking activity of neuroleptic drugs and their active metabolites. A neuroleptic drug has anti-psychotic action affecting principally psychomotor activity, is generally without hypnotic effects, and is a tranquilizer. Measurements obtained by this device are used to aid in determining whether a patient is taking the prescribed dosage level of such drugs.

Innolitics

Panel 1

/
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...